JACE EGBERT: Open Payments
NPI 1194356238 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 60 payments from 13 companies in 2025. Trend: 2023 $58 · 2024 $1,034 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $291 |
| AstraZeneca Pharmaceuticals LP | 10 | $247 |
| Lilly USA, LLC | 10 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Novo Nordisk Inc | 5 | $86 |
| Amgen Inc. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $32 |
| Dexcom, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: QULIPTA, MOUNJARO, AIRSUPRA, BREZTRI, CAPLYTA, UBRELVY, Rybelsus, OTEZLA.
Industry payments across AZ — which companies pay providers there.
